Towards Next Generation Anthelmintics.

走向下一代驱虫药。

• 批准号: LP0989954
• 负责人: Prof Robert Capon
• 金额: $ 29.83万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-07-22 至 2012-07-21
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0989954
• 关键词: Towards; Next; Generation; Anthelmintics.

The agricultural industry is in urgent need of new, safe and cost effective treatments for parasite infections in commercial livestock (sheep, cattle, goats). The current multi billion dollar agrochemical industry provides only three classes of antiparasitic drug, all of which are >25 yrs old and are largely ineffective due to the widespread resistance. This project will advance the development of a new class of antiparasitic treatment, improving outcomes for Australian farmers by reducing reliance on expensive ineffective agrochemical imports, reducing chemical load on the environment, improving pastures and increasing yields. In short, improved livestock health will lead to more sustainable and productive farming, and a stronger economy.

农业行业迫切需要新的、安全的和具有成本效益的治疗商业牲畜（绵羊、牛、山羊）寄生虫感染的方法。目前数十亿美元的农业化学工业仅提供三类抗寄生虫药物，所有这些药物都是>25年的历史，并且由于广泛的耐药性而在很大程度上无效。该项目将推动新型抗寄生虫治疗的发展，通过减少对昂贵无效的农用化学品进口的依赖，减少对环境的化学负荷，改善牧场和提高产量，改善澳大利亚农民的成果。简而言之，牲畜健康的改善将带来更可持续和更高产的农业，以及更强大的经济。